Iain B McInnes Selected Research

Iain B McInnes Research Topics

Disease

95	Rheumatoid Arthritis 01/2022 - 05/2002
74	Psoriatic Arthritis 07/2022 - 03/2007
59	Inflammation (Inflammations) 06/2022 - 05/2002
43	Arthritis (Polyarthritis) 07/2022 - 12/2002
42	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2022 - 08/2004
27	Necrosis 01/2022 - 01/2006
18	Experimental Arthritis 07/2022 - 12/2002
14	Infections 01/2022 - 02/2003
13	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 02/2003
12	Ankylosing Spondylitis 01/2022 - 01/2016
11	Synovitis 06/2020 - 05/2002
9	Pain (Aches) 01/2022 - 05/2013
9	Rheumatic Diseases (Rheumatism) 10/2021 - 10/2006
9	Tendinopathy (Tendonitis) 01/2021 - 10/2010
7	Joint Diseases (Joint Disease) 01/2022 - 08/2008
6	Atherosclerosis 06/2015 - 02/2008
5	COVID-19 01/2022 - 01/2020
5	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2022 - 07/2017
5	Disease Progression 01/2020 - 12/2007
5	Myocardial Infarction 01/2019 - 01/2010
5	Osteoarthritis 01/2018 - 11/2010
4	Hypoxia (Hypoxemia) 01/2020 - 02/2012
3	Axial Spondyloarthritis 06/2022 - 01/2019
3	Body Weight (Weight, Body) 01/2022 - 09/2010
3	Fatigue 01/2022 - 12/2018
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2021 - 01/2019
3	Herpes Zoster 10/2021 - 12/2018
3	Heart Failure 01/2020 - 07/2010
3	Cardiovascular Diseases (Cardiovascular Disease) 09/2013 - 03/2007

Drug/Important Bio-Agent (IBA)

63	CytokinesIBA 01/2022 - 07/2004
25	Biological ProductsIBA 01/2022 - 01/2009
22	secukinumabIBA 06/2022 - 02/2014
20	Interleukin-17 (Interleukin 17)IBA 01/2022 - 11/2007
19	InterleukinsIBA 06/2022 - 08/2004
19	Antirheumatic Agents (DMARD)IBA 01/2022 - 06/2004
18	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2019 - 05/2002
17	Monoclonal AntibodiesIBA 01/2022 - 11/2010
14	LipidsIBA 01/2022 - 05/2005
12	AntigensIBA 07/2022 - 07/2004
12	Interleukin-33IBA 01/2017 - 02/2008
11	C-Reactive ProteinIBA 06/2022 - 08/2013
11	Janus Kinase InhibitorsIBA 01/2022 - 09/2013
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2007
11	Adalimumab (Humira)FDA Link 10/2021 - 07/2010
11	CollagenIBA 01/2021 - 12/2002
11	Ustekinumab (CNTO 1275)FDA Link 11/2019 - 08/2013
11	Interleukin-18 (Interleukin 18)IBA 12/2018 - 01/2003
10	Interleukin-23 (Interleukin 23)IBA 01/2022 - 04/2014
10	guselkumabIBA 01/2022 - 01/2020
10	Tumor Necrosis Factor InhibitorsIBA 10/2021 - 12/2002
10	golimumab FDA Link 01/2020 - 08/2012
10	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 02/2007
9	tofacitinibIBA 07/2022 - 01/2014
9	Proteins (Proteins, Gene)FDA Link 04/2021 - 07/2004
9	ChemokinesIBA 01/2018 - 07/2008
9	Interleukin-12 (IL 12)IBA 01/2016 - 10/2004
8	AutoantibodiesIBA 04/2021 - 03/2010
8	Interleukin-15 (Interleukin 15)IBA 01/2018 - 05/2002
7	Abatacept (Orencia)FDA Link 07/2020 - 08/2010
6	tocilizumab (atlizumab)FDA Link 01/2022 - 04/2015
6	Interleukin-1 (Interleukin 1)IBA 01/2022 - 10/2004
6	Immunoglobulin G (IgG)IBA 01/2022 - 07/2004
6	AntibodiesIBA 12/2021 - 02/2008
6	Peptides (Polypeptides)IBA 04/2021 - 01/2009
5	Pharmaceutical PreparationsIBA 01/2022 - 02/2007
5	GlucocorticoidsIBA 01/2022 - 12/2018
5	Interleukin-6 (Interleukin 6)IBA 01/2022 - 08/2003
5	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020 - 09/2013
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 02/2003
5	CholesterolIBA 01/2019 - 02/2003
5	LigandsIBA 10/2016 - 04/2009
5	Collagen Type II (Type II Collagen)IBA 03/2016 - 01/2009
4	upadacitinibIBA 01/2022 - 01/2020
4	Infliximab (Remicade)FDA Link 01/2020 - 09/2010
4	Etanercept (Enbrel)FDA Link 01/2020 - 01/2016
4	AlarminsIBA 01/2019 - 05/2013
4	mavrilimumabIBA 01/2018 - 09/2013
4	Liver X ReceptorsIBA 06/2017 - 09/2009
4	MicroRNAs (MicroRNA)IBA 06/2017 - 03/2012
4	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017 - 10/2011
4	ametantrone (HAQ)IBA 01/2017 - 06/2014
4	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2016 - 07/2010
4	Lipoproteins (Lipoprotein)IBA 10/2016 - 09/2013
3	bimekizumabIBA 07/2022 - 01/2019
3	apremilastIBA 01/2022 - 11/2018
3	baricitinibIBA 01/2022 - 12/2018
3	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2022 - 06/2011
3	Janus KinasesIBA 01/2022 - 01/2020
3	pro-brain natriuretic peptide (1-76)IBA 01/2020 - 07/2010
3	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2020 - 02/2007
3	HDL CholesterolIBA 01/2019 - 09/2013
3	ProstaglandinsIBA 01/2017 - 12/2008
3	sphingosine kinaseIBA 01/2017 - 12/2008
3	Anti-Citrullinated Protein AntibodiesIBA 10/2016 - 10/2013
3	Apolipoproteins E (ApoE)IBA 06/2015 - 02/2008
3	Interleukin-10 (Interleukin 10)IBA 01/2015 - 01/2006
3	oxidized low density lipoproteinIBA 01/2015 - 02/2008

Therapy/Procedure

53	Therapeutics 01/2022 - 06/2004
6	Biological Therapy 10/2021 - 10/2006
3	Subcutaneous Injections 01/2020 - 01/2004